Ahmed M. Darwesh

Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure

Nikole J. Byrne, Nobutoshi Matsumura, Zaid H. Maayah et al. · Circulation Heart Failure · 2020 · 254 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin

Koenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi et al. · Circulation · 2021 · 197 citations · Full text

Medicine, Cardiology, Pharmacology +17

Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure

Nikole J. Byrne, Shubham Soni, Shingo Takahara et al. · Circulation Heart Failure · 2020 · 100 citations · Full text

Life Sciences, Cardiology, Physiology +16

Insulin directly stimulates mitochondrial glucose oxidation in the heart

Qutuba G. Karwi, Cory S. Wagg, Tariq Altamimi et al. · Cardiovascular Diabetology · 2020 · 64 citations · Full text

Life Sciences, Biochemistry, Physiology +17

Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation

Victor Samokhvalov, K. Lockhart Jamieson, Ahmed M. Darwesh et al. · Frontiers in Pharmacology · 2019 · 38 citations · Full text

Life Sciences, Biochemistry, Cardiology +17